Entry - #613987 - DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2 - OMIM
# 613987

DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
5q35.3 Dyskeratosis congenita, autosomal recessive 2 613987 AR 3 NHP2 606470
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
GROWTH
Other
- Poor growth
HEAD & NECK
Mouth
- Leukoplakia
ABDOMEN
Liver
- Liver cirrhosis
GENITOURINARY
External Genitalia (Male)
- Testicular atrophy
SKIN, NAILS, & HAIR
Skin
- Leukoplakia
- Reticulate skin pigmentation
Nails
- Nail dystrophy
NEUROLOGIC
Central Nervous System
- Mental retardation (1 patient)
- Intracranial calcifications (1 patient)
HEMATOLOGY
- Bone marrow failure
- Pancytopenia
- Thrombocytopenia
IMMUNOLOGY
- Opportunistic infections
LABORATORY ABNORMALITIES
- Shortened telomeres
MISCELLANEOUS
- Two unrelated patients have been reported (as of May 2011)
MOLECULAR BASIS
- Caused by mutation in the NHP2 ribonucleoprotein gene (NHP2, 606470.0001)

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive dyskeratosis congenita-2 (DKCB2) is caused by homozygous or compound heterozygous mutation in the NPH2 gene (606470) on chromosome 5q35.


Description

Dyskeratosis congenita is a multisystem disorder caused by defective telomere maintenance. Clinical manifestations include mucocutaneous abnormalities, bone marrow failure, and an increased predisposition to cancer, among other variable features (summary by Vulliamy et al., 2008).

For a discussion of genetic heterogeneity of dyskeratosis congenita, see DKCA1 (127550).


Clinical Features

Vulliamy et al. (2008) reported a Turkish man with nail dystrophy, thrombocytopenia, testicular atrophy, opportunistic infections, growth and mental retardation, liver cirrhosis, and intracranial calcification. His parents were asymptomatic and unrelated. An unrelated Turkish boy presented with dyskeratosis congenita at age 12 years. He had the classic mucocutaneous triad of nail dystrophy, leukoplakia, and reticulate skin pigmentation and developed peripheral pancytopenia due to progressive bone marrow failure. No other somatic abnormalities were reported. His parents were asymptomatic. Both patients had shortened telomeres and decreased levels of serum TERC (602322) RNA.


Molecular Genetics

In 2 unrelated Turkish patients with autosomal recessive dyskeratosis congenita, Vulliamy et al. (2008) identified biallelic mutations in the NPH2 gene (606470.0001-606470.0003). The 2 patients were identified from a larger group of 117 patients with the disorder; no other pathogenic NPH2 variants and no mutations in the GAR1 gene (606468) were identified.


REFERENCES

  1. Vulliamy, T., Beswick, R., Kirwan, M., Marrone, A., Digweed, M., Walne, A., Dokal, I. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc. Nat. Acad. Sci. 105: 8073-8078, 2008. [PubMed: 18523010, images, related citations] [Full Text]


Creation Date:
Cassandra L. Kniffin : 5/23/2011
carol : 10/12/2021
carol : 10/11/2021
alopez : 09/18/2015
carol : 5/26/2011
ckniffin : 5/25/2011

# 613987

DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 2; DKCB2


ORPHA: 1775;   DO: 0070017;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
5q35.3 Dyskeratosis congenita, autosomal recessive 2 613987 Autosomal recessive 3 NHP2 606470

TEXT

A number sign (#) is used with this entry because of evidence that autosomal recessive dyskeratosis congenita-2 (DKCB2) is caused by homozygous or compound heterozygous mutation in the NPH2 gene (606470) on chromosome 5q35.


Description

Dyskeratosis congenita is a multisystem disorder caused by defective telomere maintenance. Clinical manifestations include mucocutaneous abnormalities, bone marrow failure, and an increased predisposition to cancer, among other variable features (summary by Vulliamy et al., 2008).

For a discussion of genetic heterogeneity of dyskeratosis congenita, see DKCA1 (127550).


Clinical Features

Vulliamy et al. (2008) reported a Turkish man with nail dystrophy, thrombocytopenia, testicular atrophy, opportunistic infections, growth and mental retardation, liver cirrhosis, and intracranial calcification. His parents were asymptomatic and unrelated. An unrelated Turkish boy presented with dyskeratosis congenita at age 12 years. He had the classic mucocutaneous triad of nail dystrophy, leukoplakia, and reticulate skin pigmentation and developed peripheral pancytopenia due to progressive bone marrow failure. No other somatic abnormalities were reported. His parents were asymptomatic. Both patients had shortened telomeres and decreased levels of serum TERC (602322) RNA.


Molecular Genetics

In 2 unrelated Turkish patients with autosomal recessive dyskeratosis congenita, Vulliamy et al. (2008) identified biallelic mutations in the NPH2 gene (606470.0001-606470.0003). The 2 patients were identified from a larger group of 117 patients with the disorder; no other pathogenic NPH2 variants and no mutations in the GAR1 gene (606468) were identified.


REFERENCES

  1. Vulliamy, T., Beswick, R., Kirwan, M., Marrone, A., Digweed, M., Walne, A., Dokal, I. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc. Nat. Acad. Sci. 105: 8073-8078, 2008. [PubMed: 18523010] [Full Text: https://doi.org/10.1073/pnas.0800042105]


Creation Date:
Cassandra L. Kniffin : 5/23/2011

Edit History:
carol : 10/12/2021
carol : 10/11/2021
alopez : 09/18/2015
carol : 5/26/2011
ckniffin : 5/25/2011